Role of E3 Ligase UBR5 in Alternative Splicing during B Cell Development and Activation

Information

  • Research Project
  • 10297399
  • ApplicationId
    10297399
  • Core Project Number
    R01AI153090
  • Full Project Number
    1R01AI153090-01A1
  • Serial Number
    153090
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    8/25/2021 - 3 years ago
  • Project End Date
    7/31/2025 - 5 months from now
  • Program Officer Name
    FERGUSON, STACY E
  • Budget Start Date
    8/25/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    8/25/2021 - 3 years ago

Role of E3 Ligase UBR5 in Alternative Splicing during B Cell Development and Activation

ABSTRACT Proper B cell development is an essential part of innate and adaptive immunity. Coordination of a number of molecular mechanisms are required to facilitate B cell development, maturation, activation, and survival of B cells. Recently, the ubiquitin E3 ligase, UBR5 has been found mutated in a significant number of cases of patients with mantle cell lymphoma, implicating the E3 ligase in B cell development. UBR5 is a key regulator of DNA damage repair, transcription, translation, and our data suggests mRNA splicing via the spliceosome. UBR5 is a HECT domain ligase, which contains a cysteine residue that is responsible for ubiquitin transfer to its substrates. To elucidate the role of UBR5 in B cell maturation and activation we generated a conditional mutant disrupting the C-terminal HECT domain. Loss of the HECT domain leads to a block in maturation of B cells in the spleen with a reduction of B1 and marginal B cell subsets, as well as phenotypic alterations and functional defects of follicular B cells. Proteomic studies reveal up-regulation of spliceosome proteins in B cells lacking the HECT domain of UBR5, and that UBR5 interacts with splicing factors. To further understand the functional role of UBR5 in regulating B cells activation and maturation and the consequences of aberrant spliceosome component expression, we will define the role of UBR5 during germinal center formation and activation (Aim 1), determine the ubiquitin independent vs. dependent function in B cells (Aim2), and identify the role of spliceosome and altered transcripts in B cell activation (Aim 3). These studies will unravel a novel role of UBR5 in B cell maturation by regulating alternative splicing of key transcripts during B cell development.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    251818
  • Indirect Cost Amount
    133568
  • Total Cost
    385386
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:65386\NIGMS:320000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CMIB
  • Study Section Name
    Cellular and Molecular Immunology - B Study Section
  • Organization Name
    UNIVERSITY OF NEBRASKA MEDICAL CENTER
  • Organization Department
    GENETICS
  • Organization DUNS
    168559177
  • Organization City
    OMAHA
  • Organization State
    NE
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    681987835
  • Organization District
    UNITED STATES